United Therapeutics (UTHR) Earnings (2009 - 2026)
United Therapeutics (UTHR) earnings from Jun 30, 2009 to Mar 31, 2026. The TTM United Therapeutics (UTHR) earnings is $1.29B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
United Therapeutics (UTHR) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +6.34% |
| 3 Years TTM | +20.91% |
| 5 Years TTM | +26.00% |
| 10 Years TTM | +3.60% |
| All Time TTM | +20.46% |
Annual Earnings change of United Therapeutics (UTHR)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $275M | -79.40% |
| 2025 | $1.33B | +11.68% |
| 2024 | $1.20B | +21.35% |
| 2023 | $985M | +35.40% |
| 2022 | $727M | +52.86% |
| 2021 | $476M | -7.58% |
| 2020 | $515M | -592.63% |
| 2019 | -$105M | -117.74% |
| 2018 | $589M | +40.99% |
| 2017 | $418M | -41.45% |
| 2016 | $714M | +9.53% |
| 2015 | $652M | +91.59% |
| 2014 | $340M | +94.83% |
| 2013 | $175M | -42.66% |
| 2012 | $304M | +39.73% |
| 2011 | $218M | +105.69% |
| 2010 | $106M | +444.30% |
| 2009 | $19M | -139.45% |
| 2008 | -$49M | N/A |
Comparison United Therapeutics (UTHR) five years earnings CAGR with competitors
United Therapeutics (UTHR) five years earnings CAGR is 26.00%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +283.45% |
| INCR | INC Research Holdings Inc | 64.08% | +146.49% |
| TLRY | Tilray Brands Inc | 57.78% | +122.22% |
| PRGO | Perrigo Company plc | 51.08% | +96.48% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +32.94% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +9.16% |
| SBFM | Sunshine Biopharma Inc | 23.97% | -7.81% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | -16.69% |
| AYTU | Aytu BioPharma Inc | 21.24% | -18.29% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -33.50% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -34.87% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -54.51% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -58.80% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -59.86% |
| ZTS | Zoetis Inc - Class A | 8.54% | -67.16% |
| KMDA | Kamada Ltd | 6.87% | -73.57% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -80.67% |
| PRFX | PRF Technologies Ltd | 4.38% | -83.15% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -85.57% |
| CPHI | China Pharma Holdings Inc | 3.58% | -86.22% |
| BHC | Bausch Health Companies Inc | 3.48% | -86.61% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -88.71% |